Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Financial Officer

Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, University of Bordeaux, and Michigan State University, as well as University of California; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorder...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-08-16	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-27	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-20	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-19	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-01-03	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-11-17	Premium	bought	Premium	Premium	Premium	President and CEO
2021-08-17	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-05-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-05-14	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2020-12-28	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

IKT - Inhibikase Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for IKT